Ellington Credit Company (NYSE:EARN ) Q2 2025 Earnings Conference Call August 20, 2025 11:00 AM ET Company Participants Alaael-Deen Shilleh - Corporate Participant Associate General Counsel & Secretary - Corporate Participant Christopher Max Smernoff - Chief Financial Officer Gregory Borenstein - Corporate Participant Laurence Eric Penn - CEO, President & Trustee Conference Call Participants Douglas Michael Harter - UBS Investment Bank, Research Division Jason Price Weaver - JonesTrading Institutional Services, LLC, Research Division Operator Good morning, ladies and gentlemen. Thank you for standing by.

BHP posts lower FY25 profit and revenues on weaker iron ore prices despite record iron ore and copper output.

SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- A new securities class action has been initiated against Replimune Group, Inc. (NASDAQ: REPL) and certain executives, arising out of the company's recent stock price collapse. The lawsuit, officially known as Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), is on behalf of investors who acquired Replimune securities between November 22, 2024, and July 21, 2025.

Target Corporation's Q2 earnings beat estimates, but profitability remains under pressure with declining margins and net income down over 20%. TGT stock fell sharply due to disappointment over the internal CEO succession, raising doubts about the potential for a strategic turnaround. Bright spots include digital sales growth, strong seasonal merchandising, and expanding higher-margin revenue streams like advertising and marketplace.

SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Shares of Nutex Health Inc. (NASDAQ: NUTX) experienced a precipitous decline today, falling as much as 24% in intraday trading. The significant drop followed the company's disclosure that it would not timely submit its financial results for the quarter ended June 30, 2025 – a development related to an ongoing investigation by law firm Hagens Berman into possible securities violations.

Lower average realized crude oil and natural gas liquid prices hurt CHRD's earnings in Q2.

PLYM jumps 47% after Sixth Street offers $24.10 per share in cash to acquire all outstanding stock.

Joe Terranova, senior managing director at Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest Apple trade.

The Estée Lauder Companies Inc. (NYSE:EL ) Q4 2025 Earnings Conference Call August 20, 2025 8:30 AM ET Company Participants Akhil Shrivastava - Executive VP & CFO Laraine A. Mancini - Senior Vice President Finance & Strategy & Head of Investor Relations Stephane de la Faverie - CEO, President & Director Conference Call Participants Andrea Faria Teixeira - JPMorgan Chase & Co, Research Division Ashley Wallace - BofA Securities, Research Division Christopher Michael Carey - Wells Fargo Securities, LLC, Research Division Dara Warren Mohsenian - Morgan Stanley, Research Division Lauren Rae Lieberman - Barclays Bank PLC, Research Division Peter K.

SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Before the markets opened on July 25, 2025, investors in Centene Corporation (NYSE: CNC) saw the price of their shares decline about 10% in pre-market trading after the company reported disastrous Q2 2025 financial results. The company, a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price.

ATRenew Inc. (NYSE:RERE ) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Company Participants Chen Chen - CFO, Compliance Officer & Director Jeremy Ji - Director of Corporate Development & Investor Relations Xuefeng Chen - Co-Founder, Chairman of the Board of Directors & CEO Conference Call Participants Lixin Ju - BofA Securities, Research Division Sung-Chul Kim - Zacks Small-Cap Research Operator Good morning, and good evening, ladies and gentlemen. Thank you for standing by, and welcome to the ATRenew Inc's Second Quarter 2025 Earnings Conference Call.

Procter & Gamble's emerging market strength in Latin America and India shows resilience despite global demand concerns.

Hertz and Amazon's used-car partnership touts convenience, which strikes at the heart of Carvana's business model.

SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- On July 23, 2025, investors in Telix Pharmaceuticals Limited (NASDAQ: TLX) saw the price of their American Depositary Shares significantly fall after the company revealed that it received a subpoena from the SEC. Telix's revelation has prompted national shareholders rights firm Hagens Berman to open an investigation into whether Telix may have misled investors about certain of its drug candidates and urges Telix investors who suffered substantial losses to submit your losses now.

Strategic partnership aims to empower PGY5 orthopaedic residents with critical tools, mentorship, and resources for a successful transition into practice ROSEMONT, Ill. , Aug. 20, 2025 /PRNewswire/ -- The American Association of Orthopaedic Surgeons (AAOS) announced that Tenet Healthcare (Tenet) and United Surgical Partners International (USPI) have joined as a foundational sponsor of the inaugural AAOS Launchpad Program.

Medtronic plc MDT posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately.

Adecoagro S.A.'s Q2 2025 results showed revenue and profit declines, heavy dependence on volatile commodities, and a lack of rerating catalysts, leading to a Sell rating despite deep valuation discounts. Q2 2025 revenue fell 7% YoY to $382M, driven by lower commodity prices and weaker crushing volumes. 2025 EPS now projected at $1.31 (down from $1.45 post-Q1), still up 46% YoY but reflecting rebound, not growth.

MONSEY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Guess?

LOS ANGELES, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 12, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025, inclusive (the “Class Period”).

Meta Platforms' 22% revenue growth & AI leadership via Llama 4 overshadow Bumble's discount valuation. Despite premium pricing, META offers superior upside potential.